Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7823)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2018 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pacifico L, Andreoli GM, D’Avanzo M, De Mitri D, Pierimarchi P. Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(19): 2073-2082 [PMID: 29785076 DOI: 10.3748/wjg.v24.i19.2073] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i19/2073.htm |
| Number | Citing Articles |
| 1 |
Yan-Li Hao, Zhao-Lian Bian, Lin-Ling Ju, Yuan Liu, Gang Qin. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis. Digestive Diseases and Sciences 2020; 65(2): 470 doi: 10.1007/s10620-019-05758-5
|
| 2 |
Cui Wang, Qing Ma, Xijie Yu. Bile Acid Network and Vascular Calcification-Associated Diseases: Unraveling the Intricate Connections and Therapeutic Potential. Clinical Interventions in Aging 2023; : 1749 doi: 10.2147/CIA.S431220
|
| 3 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|
| 4 |
Mitsuhiro Isaka, Ryuji Araki, Hiroshi Ueno, Minoru Okamoto. Intestinal fatty acid-binding protein and osteoprotegerin in anthracycline-induced rabbit models of dilated cardiomyopathy. Research in Veterinary Science 2021; 140: 185 doi: 10.1016/j.rvsc.2021.09.007
|
| 5 |
Jiayan Cai, Zhenyu Zhang, Jingqi Liu, Xueling Xiao, Chizhen Wang, Manxiang Deng, Luling Chen. Correlation between serum 25‑OH vitamin D expression and non‑alcoholic fatty liver disease. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8411
|
| 6 |
Yadi Li, Yan Yang, Yufang Li, Ping Zhang, Gaiying Ge, Jing Jin, Ting Du, Maiyan Ma, Li Na, Lu Ding, Huiping Sheng. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. Journal of International Medical Research 2021; 49(11) doi: 10.1177/03000605211055378
|
| 7 |
Niklas Rye Jørgensen, Sarah Seberg Diemar, Gitte Lund Christensen, Nina Kimer, Karen Vagner Danielsen, Søren Møller. Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of Osteoprotegerin. The Journal of Clinical Endocrinology & Metabolism 2022; 107(3): e980 doi: 10.1210/clinem/dgab788
|
| 8 |
Ahmed E. Noreldin, Islam M. Saadeldin, Norhan E. Khalifa, Asmaa F. Khafaga. Emerging Therapeutic Potential of Short Mitochondrial-produced Peptides for Anabolic Osteogenesis. International Journal of Peptide Research and Therapeutics 2022; 28(1) doi: 10.1007/s10989-021-10353-2
|
| 9 |
Reyhaneh Darvish Damavandi, Farzad Shidfar, Mohammad Najafi, Leila Janani, Mohsen Masoodi, Javad Heshmati, Somayeh Ziaei. Effect of portulaca oleracea (purslane) extract on inflammatory factors in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. Journal of Functional Foods 2023; 102: 105465 doi: 10.1016/j.jff.2023.105465
|
| 10 |
Shaobo Wu, Yao Wu, Lan Lin, Changshun Ruan, Fang Li, Rong Chen, Hongxin Du, Xianxiang Zhang, Xiaohe Luo. Osteoprotegerin deficiency aggravates methionine–choline-deficient diet-induced nonalcoholic steatohepatitis in mice. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30001-7
|
| 11 |
Mohsen Nikseresht, Nahid Azarmehr, Arash Arya, Behnam Alipoor, Reza Fadaei, Bahman Khalvati, Hassan Abidi, Amir Hossein Doustimotlagh. Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF‐κB ligand in nonalcoholic fatty liver disease. Biotechnology and Applied Biochemistry 2020; doi: 10.1002/bab.2047
|
| 12 |
Laís Cristina Giacobbo, Maria Augusta Andrigo Perin, Thaís Munhoz Pereira, Mariana Oliveira Garmendia, Alexandre Reichow, Ana Cláudia Melo, Bruno Borges de Castilhos, Paula Cristina Trevilatto. RANK/RANKL/OPG gene polymorphisms and loss of orthodontic mini‐implants. Orthodontics & Craniofacial Research 2020; 23(2): 210 doi: 10.1111/ocr.12360
|
| 13 |
Yuanyuan Zhang, Juyi Li, Yingqun Ni, Yan Wang, Huaizhen Liu. Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00762-1
|
| 14 |
Doaa El Amrousy, Dalia El-Afify. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. Cytokine 2020; 135: 155215 doi: 10.1016/j.cyto.2020.155215
|
| 15 |
Ilias D. Vachliotis, Stergios A. Polyzos. Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease. Current Obesity Reports 2023; 12(2): 147 doi: 10.1007/s13679-023-00505-4
|
| 16 |
Samira Zein Sayed, Asmaa Hosni Abd El-Hafez, Mostafa Ahmed Abu El-ela, Mohamed Aboul-fotouh Mourad, Suzan Omar Mousa. OPG/RANK/RANKL axis relation to cardiac iron-overload in children with transfusion-dependent thalassemia. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-39596-3
|